Literature DB >> 28478536

Percent mammographic density prediction: development of a model in the nurses' health studies.

Megan S Rice1, Bernard A Rosner2, Rulla M Tamimi2,3.   

Abstract

PURPOSE: To develop a model to predict percent mammographic density (MD) using questionnaire data and mammograms from controls in the Nurses' Health Studies' nested breast cancer case-control studies. Further, we assessed the association between both measured and predicted percent MD and breast cancer risk.
METHODS: Using data from 2,955 controls, we assessed several variables as potential predictors. We randomly divided our dataset into a training dataset (two-thirds of the dataset) and a testing dataset (one-third of the dataset). We used stepwise linear regression to identify the subset of variables that were most predictive. Next, we examined the correlation between measured and predicted percent MD in the testing dataset and computed the r 2 in the total dataset. We used logistic regression to examine the association between measured and predicted percent MD and breast cancer risk.
RESULTS: In the training dataset, several variables were selected for inclusion, including age, body mass index, and parity, among others. In the testing dataset, the Spearman correlation coefficient between predicted and measured percent MD was 0.61. As the prediction model performed well in the testing dataset, we developed the final model in the total dataset. The final prediction model explained 41% of the variability in percent MD. Both measured and predicted percent MD were similarly associated with breast cancer risk adjusting for age, menopausal status, and hormone use (OR per five unit increase = 1.09 for both).
CONCLUSION: These results suggest that predicted percent MD may be useful for research studies in which mammograms are unavailable.

Entities:  

Keywords:  Breast cancer; Mammographic density; Prediction model

Mesh:

Year:  2017        PMID: 28478536      PMCID: PMC5568000          DOI: 10.1007/s10552-017-0898-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  35 in total

1.  Family history, mammographic density, and risk of breast cancer.

Authors:  Lisa J Martin; Olga Melnichouk; Helen Guo; Anna M Chiarelli; T Gregory Hislop; Martin J Yaffe; Salomon Minkin; John L Hopper; Norman F Boyd
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

2.  Reproductive and lifestyle risk factors and mammographic density in Mexican women.

Authors:  Megan S Rice; Kimberly A Bertrand; Martin Lajous; Rulla M Tamimi; Gabriela Torres; Ruy López-Ridaura; Isabelle Romieu
Journal:  Ann Epidemiol       Date:  2015-08-29       Impact factor: 3.797

3.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

Authors:  Amy E Millen; Jean Wactawski-Wende; Mary Pettinger; Michal L Melamed; Frances A Tylavsky; Simin Liu; John Robbins; Andrea Z LaCroix; Meryl S LeBoff; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

4.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study.

Authors:  Enju Liu; James B Meigs; Anastassios G Pittas; Christina D Economos; Nicola M McKeown; Sarah L Booth; Paul F Jacques
Journal:  Am J Clin Nutr       Date:  2010-04-14       Impact factor: 7.045

Review 5.  Mammographic breast density as an intermediate phenotype for breast cancer.

Authors:  Norman F Boyd; Johanna M Rommens; Kelly Vogt; Vivian Lee; John L Hopper; Martin J Yaffe; Andrew D Paterson
Journal:  Lancet Oncol       Date:  2005-10       Impact factor: 41.316

6.  Mammographic features of the breast and breast cancer risk.

Authors:  J Brisson; F Merletti; N L Sadowsky; J A Twaddle; A S Morrison; P Cole
Journal:  Am J Epidemiol       Date:  1982-03       Impact factor: 4.897

7.  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Authors:  Jeffrey A Tice; Steven R Cummings; Rebecca Smith-Bindman; Laura Ichikawa; William E Barlow; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

8.  Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.

Authors:  Jane Warwick; Hanna Birke; Jennifer Stone; Ruth M L Warren; Elizabeth Pinney; Adam R Brentnall; Stephen W Duffy; Anthony Howell; Jack Cuzick
Journal:  Breast Cancer Res       Date:  2014-10-08       Impact factor: 6.466

9.  Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods.

Authors:  Amanda Eng; Zoe Gallant; John Shepherd; Valerie McCormack; Jingmei Li; Mitch Dowsett; Sarah Vinnicombe; Steve Allen; Isabel dos-Santos-Silva
Journal:  Breast Cancer Res       Date:  2014-09-20       Impact factor: 6.466

10.  Mammographic density and breast cancer risk: a mediation analysis.

Authors:  Megan S Rice; Kimberly A Bertrand; Tyler J VanderWeele; Bernard A Rosner; Xiaomei Liao; Hans-Olov Adami; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2016-09-21       Impact factor: 6.466

View more
  9 in total

1.  Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk.

Authors:  Lusine Yaghjyan; Akemi Wijayabahu; A Heather Eliassen; Graham Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2020-05-31       Impact factor: 2.506

2.  Alcohol consumption across the life course and mammographic density in premenopausal women.

Authors:  Ying Liu; Rulla M Tamimi; Graham A Colditz; Kimberly A Bertrand
Journal:  Breast Cancer Res Treat       Date:  2017-09-26       Impact factor: 4.872

3.  Association of Interactions Between Mammographic Density Phenotypes and Established Risk Factors With Breast Cancer Risk, by Tumor Subtype and Menopausal Status.

Authors:  Hongjie Chen; Lusine Yaghjyan; Christopher Li; Ulrike Peters; Bernard Rosner; Sara Lindström; Rulla M Tamimi
Journal:  Am J Epidemiol       Date:  2021-01-04       Impact factor: 4.897

4.  Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women.

Authors:  Lusine Yaghjyan; Carmen Smotherman; John Heine; Graham A Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-12-03       Impact factor: 4.090

5.  Interactions of alcohol and postmenopausal hormone use in regards to mammographic breast density.

Authors:  Lusine Yaghjyan; Graham Colditz; Heather Eliassen; Bernard Rosner; Aleksandra Gasparova; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2018-06-25       Impact factor: 2.506

6.  Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study.

Authors:  Erica T Warner; Megan S Rice; Oana A Zeleznik; Erin E Fowler; Divya Murthy; Celine M Vachon; Kimberly A Bertrand; Bernard A Rosner; John Heine; Rulla M Tamimi
Journal:  NPJ Breast Cancer       Date:  2021-05-31

7.  Residential particulate matter and distance to roadways in relation to mammographic density: results from the Nurses' Health Studies.

Authors:  Natalie C DuPre; Jaime E Hart; Kimberly A Bertrand; Peter Kraft; Francine Laden; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2017-11-23       Impact factor: 6.466

8.  Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci.

Authors:  Hongjie Chen; Shaoqi Fan; Jennifer Stone; Deborah J Thompson; Julie Douglas; Shuai Li; Christopher Scott; Manjeet K Bolla; Qin Wang; Joe Dennis; Kyriaki Michailidou; Christopher Li; Ulrike Peters; John L Hopper; Melissa C Southey; Tu Nguyen-Dumont; Tuong L Nguyen; Peter A Fasching; Annika Behrens; Gemma Cadby; Rachel A Murphy; Kristan Aronson; Anthony Howell; Susan Astley; Fergus Couch; Janet Olson; Roger L Milne; Graham G Giles; Christopher A Haiman; Gertraud Maskarinec; Stacey Winham; Esther M John; Allison Kurian; Heather Eliassen; Irene Andrulis; D Gareth Evans; William G Newman; Per Hall; Kamila Czene; Anthony Swerdlow; Michael Jones; Marina Pollan; Pablo Fernandez-Navarro; Daniel S McConnell; Vessela N Kristensen; Joseph H Rothstein; Pei Wang; Laurel A Habel; Weiva Sieh; Alison M Dunning; Paul D P Pharoah; Douglas F Easton; Gretchen L Gierach; Rulla M Tamimi; Celine M Vachon; Sara Lindström
Journal:  Breast Cancer Res       Date:  2022-04-12       Impact factor: 6.466

9.  The Chilean Maternal-Infant Cohort Study-II in the COVID-19 Era: A Study Protocol.

Authors:  María F Mujica-Coopman; Camila Corvalán; Marcela Flores; María Luisa Garmendia
Journal:  Front Public Health       Date:  2022-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.